Hinge Health vs LiveRamp
HNGE and RAMP side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HNGE and RAMP compare
Hinge Health is the larger company, worth 3.9 times as much as LiveRamp ($9.2B against $2.3B).
Hinge Health grew revenue faster over the last twelve months (49.8% versus 8.9% for LiveRamp).
LiveRamp keeps more of each dollar of sales as profit, with a net margin of 18.7% compared with 15.1% at Hinge Health.
LiveRamp scores higher on the StockData Score (17 against 11 for Hinge Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HNGE | RAMP |
|---|---|---|
| Size and price | ||
| Market cap | $9.2B | $2.3B |
| Share price | $114.32 | $38.50 |
| Change, 1 year | 130% | 41.8% |
| Change, 5 years | – | −30.4% |
| Beta (5Y) | 1.68 | 1.35 |
| Employees | 1,437 | 1,300 |
| StockData Score | ||
| Total score | 11 | 17 (better) |
| Valuation score | 0 | 5 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 2 | 4 (better) |
| Health score | 6 | 6 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 15.8× |
| P/S | 12.8× | 2.8× (better) |
| P/B | 26.8× | 2.4× (better) |
| EV/EBITDA | 89.8× | 17.9× (better) |
| P/FCF | 31.8× | 11.8× (better) |
| FCF yield | 3.1% | 8.5% (better) |
| Fair value | – | $53.76 |
| Margin of safety | – | 28.4% |
| Growth | ||
| Revenue growth (TTM) | 49.8% (better) | 8.9% |
| Revenue growth, 5Y average | – | 12.9% |
| Net income growth (TTM) | – | 980% |
| EPS growth (TTM) | – | 1009% |
| Profitability | ||
| Gross margin | 84.5% (better) | 70.8% |
| Operating margin | 13.0% (better) | 11.6% |
| Net margin | 15.1% | 18.7% (better) |
| FCF margin | 40.3% (better) | 23.9% |
| Return on equity | 42.1% (better) | 16.2% |
| Return on invested capital | – | 16.3% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 1.34 | 2.66 (better) |
| Altman Z-score | 11.29 (better) | 7.55 |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 7.6% |
| Shareholder yield | 0.00% | 7.6% (better) |
| Ownership | ||
| Held by institutions | 72.0% | 102% |
| Held by insiders | 50.7% | 4.5% |
| Insider net buying, 12 months | −$517M | −$170K (better) |
| Short interest, % of float | 15.9% | 14.7% |
Go deeper
- HNGE stock overview
- HNGE income statement
- HNGE valuation and score
- RAMP stock overview
- RAMP income statement
- RAMP valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.